Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
148.8 USD | -3.50% | -2.53% | -17.47% |
Sales 2024 * | 323.89Cr 27TCr | Sales 2025 * | 402.23Cr 34TCr | Capitalization | 1.56TCr 1,29800Cr |
---|---|---|---|---|---|
Net income 2024 * | -86Cr -7.17TCr | Net income 2025 * | -35Cr -2.89TCr | EV / Sales 2024 * | 4.31 x |
Net cash position 2024 * | 160.31Cr 13TCr | Net cash position 2025 * | 100.58Cr 8.39TCr | EV / Sales 2025 * | 3.62 x |
P/E ratio 2024 * |
-16.5
x | P/E ratio 2025 * |
-38.2
x | Employees | 10,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on BeiGene, Ltd.
1 day | -3.50% | ||
1 week | -2.53% | ||
1 month | -4.91% | ||
3 months | -9.80% | ||
6 months | -20.61% | ||
Current year | -17.47% |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.48% | 4 M€ | -27.92% | ||
1.49% | 0 M€ | 0.00% | - | |
1.39% | 9 M€ | -4.31% | - |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 148.8 | -3.50% | 287,022 |
30/24/30 | 154.2 | +1.96% | 208,503 |
29/24/29 | 151.3 | -1.20% | 73,381 |
28/24/28 | 153.1 | +0.26% | 119,851 |
24/24/24 | 152.7 | -2.22% | 144,597 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.47% | 1.56TCr | |
+11.60% | 11TCr | |
-4.68% | 2.43TCr | |
-0.82% | 2.2TCr | |
-10.12% | 1.82TCr | |
-42.12% | 1.64TCr | |
+2.77% | 1.36TCr | |
+34.58% | 1.23TCr | |
+77.64% | 887.31Cr | |
+7.26% | 774.73Cr |
- Stock Market
- Equities
- BGNE Stock